Effect of Aspirin Continuation on Blood Loss and Postoperative Morbidity in Patients Undergoing Laparoscopic Cholecystectomy or Colorectal Cancer Resection
| Autor: | Kazumi Ono, Kazuhito Kusudo, Hidekuni Hidaka, Shinya Taguchi, Hitoshi Idani, Yusuke Koyama |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
Reoperation medicine.medical_specialty Blood transfusion Colorectal cancer medicine.medical_treatment Blood Loss Surgical Blood loss Preoperative Care medicine Humans Blood Transfusion In patient Prospective Studies Prospective cohort study Aged Postoperative Care Aspirin business.industry General surgery Length of Stay Middle Aged medicine.disease Conversion to Open Surgery Surgery Cholecystectomy Laparoscopic Female Laparoscopy Cholecystectomy Colorectal Neoplasms business Platelet Aggregation Inhibitors Abdominal surgery medicine.drug |
| Zdroj: | Surgical Laparoscopy, Endoscopy & Percutaneous Techniques. 23:97-100 |
| ISSN: | 1530-4515 |
| DOI: | 10.1097/sle.0b013e318278cdf8 |
| Popis: | No consensus exists whether to continue or withdraw aspirin therapy perioperatively in patients undergoing major laparoscopic abdominal surgery. To investigate whether preoperative continuation of aspirin therapy increases blood loss and associated morbidity during laparoscopic cholecystectomy and colorectal cancer resection, we compared duration of surgical procedures, amount of intraoperative blood loss, rate of blood transfusion, length of postoperative stay, rate of conversion to open surgery, and reoperation within 48 hours between patients with and without aspirin therapy preoperatively. Twenty-nine of 270 patients who underwent laparoscopic cholecystectomy and 23 of 218 patients who underwent laparoscopic colorectal cancer resection, respectively, were on aspirin therapy. We found no significant difference in the investigated outcome between groups with the exception of longer surgical duration of laparoscopic cholecystectomy in aspirin-treated patients. Although underpowered, above findings may suggest that aspirin continuation is unlikely to increase blood loss or postoperative morbidity in patients undergoing laparoscopic cholecystectomy or colorectal cancer resection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|